Article

jdsupra.com on 2022-07-08 02:56

OIG Issues Favorable Advisory Opinion Involving an Arrangement With 0% Financing Options for a DME Manufacturer’s Customers

On June 17, 2022, OIG issued a favorable advisory opinion allowing involving an arrangement in which a durable medical equipment (DME) manufacturer ...

Related news

OIG Advisory Opinion 18-04: Another Favorable Medigap/PHO Arrangement jdsupra.com
California , United States , Switzerland
OIG Issues Favorable Advisory Opinion Addressing Gainsharing CMP Arrangement jdsupra.com
OIG Issues Favorable Advisory Opinion for Free Drug Sample Arrangement jdsupra.com
OIG Issues Favorable Advisory Opinion of Hospital Leasing Arrangement jdsupra.com
OIG Issues Favorable Advisory Opinion Regarding Wholly Owned GPO Arrangement jdsupra.com
HHS-OIG Issues Favorable Opinion on Gainsharing Arrangement jdsupra.com
OIG Issues Additional Favorable Advisory Opinion Regarding Medigap Plan and Preferred Hospital Organization Arrangement jdsupra.com
OIG Issues Favorable Advisory Opinion Regarding Chiropractor Arrangement to Offer Discounts jdsupra.com
OIG Issues Favorable Advisory Opinion Regarding Laboratory Arrangement to Offer Discounts jdsupra.com
OIG Issues Favorable Advisory Opinion On Arrangement between Medigap Plan And Hospital Network jdsupra.com
OIG Issues Favorable Advisory Opinion Regarding Employee Lease Arrangement Between Related Entities jdsupra.com
OIG Issues Favorable Advisory Opinion on Critical Access Hospital’s Warranty-Like Arrangement for Certain Joint Replacement Procedures jdsupra.com
OIG Issues Favorable Advisory Opinion Regarding Biopharmaceutical Company Arrangement to Provide Free Genetic Testing and Counseling to Potentially Eligible Patients jdsupra.com
United States
OIG Issues Favorable Advisory Opinion Regarding Pharmaceutical Manufacturer Arrangement to Provide Financial Assistance to Potentially Eligible Patients jdsupra.com
OIG Greenlights Manufacturer’s Limited Free Drug Program jdsupra.com
United States
OIG Issues Favorable Advisory Opinion on a Drug Manufacturer’s Provision to Hospitals of Trial Units of Antipsychotic Medication for Inpatient Use jdsupra.com
OIG Continues to Recommend Reduced Medicaid DME Reimbursement Rates jdsupra.com
Ohio , New York , Minnesota , California
OIG Approves DME Manufacturer Loan Program in Latest Advisory Opinion jdsupra.com
OIG Approves Manufacturer’s Offer of Free Genetic Testing jdsupra.com
OIG OKs Physician Consultant Gift Card Arrangement jdsupra.com